Close
4

Bora CDMO Bora CDMO

X

CAS 3663-80-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 3663-80-7
Also known as: 3663-80-7, 1,4-benzodioxan-2-carboxylic acid, 2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylic acid, 2,3-dihydro-1,4-benzodioxine-2-carboxylic acid, 34385-93-8, 1,4-benzodioxin-2-carboxylic acid, 2,3-dihydro-
Molecular Formula
C9H8O4
Molecular Weight
180.16  g/mol
InChI Key
HMBHAQMOBKLWRX-UHFFFAOYSA-N
FDA UNII
T9Z56HV1B0

1 2D Structure

CAS 3663-80-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3-dihydro-1,4-benzodioxine-3-carboxylic acid
2.1.2 InChI
InChI=1S/C9H8O4/c10-9(11)8-5-12-6-3-1-2-4-7(6)13-8/h1-4,8H,5H2,(H,10,11)
2.1.3 InChI Key
HMBHAQMOBKLWRX-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(OC2=CC=CC=C2O1)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
T9Z56HV1B0
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 3663-80-7

2. 1,4-benzodioxan-2-carboxylic Acid

3. 2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylic Acid

4. 2,3-dihydro-1,4-benzodioxine-2-carboxylic Acid

5. 34385-93-8

6. 1,4-benzodioxin-2-carboxylic Acid, 2,3-dihydro-

7. Rac 1,4-benzodioxane-2-carboxylic Acid

8. Doxazosin Impurity A

9. 2,3-dihydro-1,4-benzodioxine-3-carboxylic Acid

10. (2rs)-2,3-dihydro-1,4-benzodioxine-2-carboxylic Acid

11. 1,4-benzodioxane 2-carboxylic Acid

12. Rx 811056

13. Rx-811056

14. T9z56hv1b0

15. (+/-)-1,4-benzodioxan-2-carboxylic Acid

16. 2,3-dihydro-1,4-benzodioxin-2-carboxylic Acid

17. 2,3-dihydrobenzo(b)(1,4)dioxine-2-carboxylic Acid

18. Mfcd00084888

19. 2,3-dihydrobenzo[1,4]dioxine-2-carboxylic Acid

20. (s)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylic Acid

21. Unii-t9z56hv1b0

22. Cholinehydroxide

23. Doxazosin Mesilate Impurity A [ep]

24. Cds1_000297

25. Usp Doxazosin Related Compound D [usp]

26. Maybridge1_002585

27. Usp Doxazosin Related Compound D Rs [usp]

28. Chemdiv2_003276

29. 2-benzodioxanecarboxylic Acid

30. Oprea1_073520

31. Divk1c_001337

32. Schembl229498

33. Hms548n11

34. Dtxsid30957891

35. Usp Doxazosin Related Compound D

36. Hms1378e20

37. Act09619

38. Albb-004760

39. Doxazosin Related Compound D

40. Str04611

41. 1,4-benzodiozane-2-carboxylic Acid

42. Bbl001421

43. Stk183543

44. Akos000271138

45. Akos016040108

46. Ac-1644

47. Am10812

48. Ccg-202901

49. Cs-w002348

50. Pb43330

51. Sdccgmls-0065916.p001

52. Sy003328

53. 1,4-benzodioxan-2-carboxylic Acid, 97%

54. 1-(o-tolyl)piperazinedihydrochloride

55. Db-048985

56. A6320

57. B3406

58. Eu-0033210

59. Ft-0606770

60. Ft-0630207

61. Ft-0650411

62. Ft-0651340

63. Doxazosin Related Compound D [usp-rs]

64. 63b807

65. 2,3-dihydro-benzo[1,4]dioxine-2-carboxylic Acid

66. Sr-01000597134

67. 12w-0825

68. 2,3-dihydrobenzo[b][1,4]dioxine-2-carboxylicacid

69. Doxazosin Mesilate Impurity A [ep Impurity]

70. J-507002

71. Sr-01000597134-1

72. 2,3-dihydrobenzo [b][1,4]dioxine-2-carboxylic Acid

73. Q27289857

74. Z56839652

75. F0913-5472

76. Usp Doxazosin Related Compound D [usp Impurity]

77. Doxazosin Related Compound D, United States Pharmacopeia (usp) Reference Standard

78. 5-[5-(5-chloro-1h-indol-2-yl)-1,2,4-oxadiazol-3-yl]-1-(3-oxo-3-pyrrolidin-1-ylpropyl)-1h-benzimidazole

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 180.16 g/mol
Molecular Formula C9H8O4
XLogP31.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass180.04225873 g/mol
Monoisotopic Mass180.04225873 g/mol
Topological Polar Surface Area55.8 Ų
Heavy Atom Count13
Formal Charge0
Complexity204
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY